Mieloma Dokter Terbaik di Israel - TOP-18 dokter

Profesor Ron Ram berpraktik di Sourasky Medical Center (Ichilov), rumah sakit universitas terbesar di Israel.

• Rekan sejawat Profesor Fredi Aviv mengepalai Unit Transplantasi Sumsum Tulang di sana
• Tim ini berspesialisasi dalam kanker hematologi, termasuk mieloma
• Menggunakan pengobatan mutakhir seperti imunoterapi seluler
• Pusat ini memimpin dalam riset transplantasi sel induk autologus

Dr. Ron Ram telah melakukan beberapa ratus transplantasi sel induk di Sourasky Medical Center – sebuah prosedur utama untuk mengobati Myeloma.

• Tersertifikasi dalam Penyakit Dalam, Hematologi, dan Onkologi Medis
• Menerbitkan lebih dari 30 artikel ilmiah dan satu bab buku teks tentang hematologi
• Menyelesaikan fellowship Hematologi dan Onkologi di New York Medical College
• Menawarkan pendekatan individual untuk setiap pasien transplantasi

Dr. El Hasid telah melakukan lebih dari 300 transplantasi sumsum tulang dan darah tali pusat pada anak-anak. Beliau memimpin Departemen Onkohematologi dan Onkologi Anak di Rumah Sakit Anak Dana Dwek.

• Spesialisasi dalam transplantasi sumsum tulang dan darah tali pusat pediatrik
• Menjadi anggota American Association for Hematology
• Menjadi anggota Israeli Society for Pediatric Hematooncology
• Menjalani pelatihan di Rumah Sakit City of Hope yang ternama di Los Angeles
• Menulis 50 publikasi dan 40 laporan konferensi

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Michael Shapira adalah seorang ahli hematologi senior yang dikenal karena membuktikan bahwa usia bukanlah penghalang bagi keberhasilan transplantasi sel punca. Beliau mengepalai Unit Rawat Inap Hematologi dan Rumah Sakit Siang di Tel Aviv Sourasky Medical Center.

• Spesialisasi dalam transplantasi sumsum tulang untuk pasien dewasa lanjut usia
• Mengobati penyakit graft versus host (GVHD)
• Sebelumnya merupakan dokter senior di Departemen Transplantasi Sel Punca di Rumah Sakit Hadassah Ein Kerem
• Menjadi anggota dari beberapa asosiasi medis internasional
• Lulus dari fakultas kedokteran Hebrew University of Jerusalem

Dr. Fredi Aviv telah berfokus pada Myeloma selama 31 tahun di Sourasky Medical Center utama di Tel Aviv.

• Spesialisasi sebagai Onkohematolog, khususnya menangani kanker darah
• Memiliki pengalaman luas dalam mengelola protokol perawatan kanker darah yang kompleks
• Bekerja di salah satu pusat medis terkemuka dan terlengkap di Israel

Dr. Dror Levin adalah ahli terkemuka dalam kelainan darah pediatrik dan kanker tulang, yang memimpin departemen onkologi hematologi anak di Sourasky Medical Center.

• Spesialisasi dalam mengobati kanker tulang (sarkoma) pada anak-anak
• Anggota asosiasi Israel untuk hemato-onkologi pediatrik (ISPHO)
• Berlatih di Institut Ortopedi Rizzoli di Italia – pemimpin dunia dalam onkologi tulang
• Mengoordinasikan pengobatan untuk gangguan pembekuan darah pada anak-anak

Dr. Kirshner terlibat aktif dalam penelitian myeloma dan uji klinis, termasuk uji coba fase III yang menguji kombinasi pengobatan baru.

• Menyelesaikan pelatihan spesialis (Fellowship) di bidang hematologi dan onkologi medis di Montefiore Medical Center
• Spesialisasi dalam pendekatan pengobatan lanjutan untuk myeloma
• Memiliki pengalaman kerja yang panjang di Sourasky Medical Center yang bergengsi
• Sertifikasi dewan dalam ilmu penyakit dalam dan onkologi

Dr. Yair adalah seorang spesialis hematologi peraih penghargaan di Sourasky Medical Center, yang ahli dalam menangani kanker darah seperti mieloma.

• Menerima berbagai hibah penelitian dan penghargaan atas kontribusinya di bidang hematologi
• Anggota dari Asosiasi Hematologi Israel dan Amerika
• Pelatihan ekstensif di bidang hematologi di Tel Aviv Medical Center

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Onkohematolog Ofer Spielberg menangani kanker darah di Assuta Medical Center.

• Spesialisasi khusus dalam menangani mieloma dan gangguan darah lainnya
• Bekerja di dalam jaringan rumah sakit besar Israel yang dikenal dengan onkologi mutakhir

Profesor Ben-Yehuda adalah Kepala Hematologi di Hadassah Medical Center dan Dekan Fakultas Kedokteran yang diakui.

• Memiliki pengalaman lebih dari 30 tahun dalam menangani penyakit darah ganas termasuk mieloma
• Menempuh pelatihan di Memorial Sloan-Kettering Cancer Center yang bergengsi di New York
• Spesialisasi dalam transplantasi sumsum tulang dan terapi gen lanjutan
• Memimpin penelitian dalam diagnostik molekuler untuk penyakit hematologi
• Penerima penghargaan Healing with the Heart untuk perawatan pasien yang luar biasa